NCT00694720View on ClinicalTrials.gov

Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Heart FailureSleep Apnea SyndromesCheyne-Stokes Respiration
Interventions
DRUG

AVE0657

capsules once a day at bedtime

DRUG

placebo

capsules once a day at bedtime

Trial Locations (3)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Barcelona

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY